145 related articles for article (PubMed ID: 8566162)
21. Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner.
Law PY; McGinn TM; Campbell KM; Erickson LE; Loh HH
Mol Pharmacol; 1997 Jan; 51(1):152-60. PubMed ID: 9016358
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
Lupica CR; Proctor WR; Dunwiddie TV
Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors.
Katsumata S; Minami M; Nakagawa T; Iwamura T; Satoh M
Eur J Pharmacol; 1995 Nov; 291(3):367-73. PubMed ID: 8719422
[TBL] [Abstract][Full Text] [Related]
24. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
Martin NA; Prather PL
Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors.
Katsumata S; Ienaga Y; Minami M; Nakagawa T; Kanematsu K; Satoh M
Eur J Pharmacol; 1996 Oct; 312(3):349-55. PubMed ID: 8894618
[TBL] [Abstract][Full Text] [Related]
26. delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Henderson G
Br J Pharmacol; 1996 Jan; 117(2):333-40. PubMed ID: 8789387
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
Poonyachoti S; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
[TBL] [Abstract][Full Text] [Related]
28. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
29. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
[TBL] [Abstract][Full Text] [Related]
30. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
31. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
32. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
[TBL] [Abstract][Full Text] [Related]
34. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
Obermeier H; Wehmeyer A; Schulz R
Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
Kamei J; Saitoh A; Ohsawa M; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1995 Mar; 276(1-2):131-5. PubMed ID: 7781682
[TBL] [Abstract][Full Text] [Related]
36. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
37. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
38. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
Knapp RJ; Sharma SD; Toth G; Duong MT; Fang L; Bogert CL; Weber SJ; Hunt M; Davis TP; Wamsley JK
J Pharmacol Exp Ther; 1991 Sep; 258(3):1077-83. PubMed ID: 1653834
[TBL] [Abstract][Full Text] [Related]
39. Different effects of NMDA/group I metabotropic glutamate receptor agents in delta- and mu-opioid receptor agonist-induced supraspinal antinociception.
Suzuki T; Aoki T; Ohnishi O; Nagase H; Narita M
Eur J Pharmacol; 2000 May; 396(1):23-8. PubMed ID: 10822049
[TBL] [Abstract][Full Text] [Related]
40. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
Tao PL; Tsai CL; Chang LR; Loh HH
Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
